Six-month therapy with aerosolized interferon-gamma for refractory multidrug-resistant pulmonary tuberculosis.
about
Immunotherapy for tuberculosis: future prospectsRising to the challenge: new therapies for tuberculosisEfficacy of Mycobacterium indicus pranii immunotherapy as an adjunct to chemotherapy for tuberculosis and underlying immune responses in the lungAdjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study.The immunology of tuberculosis: from bench to bedside.Pharmacotherapy for multidrug resistant tuberculosis.Antitubercular inhaled therapy: opportunities, progress and challenges.Immunological options for the treatment of tuberculosis: evaluation of novel therapeutic approaches.CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease.Cytokine therapy of tuberculosis at the crossroads.Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Insights from the Society of Infectious Diseases Pharmacists.Host-Directed Therapies for Tuberculosis.Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects.Age predicts cytokine kinetics and innate immune cell activation following intranasal delivery of IFNγ and GM-CSF in a mouse model of RSV infection.Host-Directed Therapeutic Strategies for Tuberculosis.
P2860
Q26741261-69D8145A-FDDF-4D43-AA4E-35FF0195E40BQ27011672-48E95279-3F36-4966-9227-9D8CE5DC0DE4Q28481571-63900AEA-F909-4319-A888-FF15B1E4AF57Q33319304-9E111203-2A6B-4391-B157-032A994DFEDDQ33777367-9C8647FC-4CD9-4349-A16B-EC525BA71F47Q35975304-4A169AA6-2DF9-4F48-B4CE-7C25CA06A593Q36068001-7EE3991B-5377-4469-92BD-8072119D24F7Q36839739-8ECA445A-4F8B-4A77-9469-963BA9755056Q36951532-EE892D38-20B2-47EA-8315-7CA89A6BD573Q37754962-40519D44-75F3-4140-99FC-1C750B2CA2A1Q37760514-D4E34BAB-A37B-485C-824D-256EB1C37396Q38489473-DAADAAD2-A1C0-446D-8D5F-AF66B47C2B60Q39967041-BFDB8258-E7CC-47F7-AB5D-2DC16F11F2E1Q40180526-7FF6065A-4DF7-494B-9186-DF4040F3B2BEQ45006012-04715555-7E12-468F-978C-8AD9241848E2
P2860
Six-month therapy with aerosolized interferon-gamma for refractory multidrug-resistant pulmonary tuberculosis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Six-month therapy with aerosol ...... istant pulmonary tuberculosis.
@ast
Six-month therapy with aerosol ...... istant pulmonary tuberculosis.
@en
type
label
Six-month therapy with aerosol ...... istant pulmonary tuberculosis.
@ast
Six-month therapy with aerosol ...... istant pulmonary tuberculosis.
@en
prefLabel
Six-month therapy with aerosol ...... istant pulmonary tuberculosis.
@ast
Six-month therapy with aerosol ...... istant pulmonary tuberculosis.
@en
P2093
P2860
P1476
Six-month therapy with aerosol ...... istant pulmonary tuberculosis.
@en
P2093
Gee Young Suh
Hojoong Kim
Kyung Soo Lee
Man Pyo Chung
Nam Yong Lee
O Jung Kwon
Tae Sung Kim
Won-Jung Koh
P2860
P304
P356
10.3346/JKMS.2004.19.2.167
P577
2004-04-01T00:00:00Z